Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

B artonella endocarditis masquerading as systemic vasculitis with rapidly progressive glomerulonephritis (aka 'Löhlein nephritis').

Bannon L, Choshen G, Giladi M, Ablin J.

BMJ Case Rep. 2019 Dec 3;12(12). pii: e231413. doi: 10.1136/bcr-2019-231413.

PMID:
31801777
2.

Cannabinoids in the treatment of rheumatic diseases: Pros and cons.

Sarzi-Puttini P, Ablin J, Trabelsi A, Fitzcharles MA, Marotto D, Häuser W.

Autoimmun Rev. 2019 Dec;18(12):102409. doi: 10.1016/j.autrev.2019.102409. Epub 2019 Oct 21. Review.

PMID:
31648042
3.

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W.

Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.

PMID:
31512536
4.

The Relation of Physical Comorbidity and Multimorbidity to Fibromyalgia, Widespread Pain, and Fibromyalgia-related Variables.

Wolfe F, Ablin J, Guymer EK, Littlejohn GO, Rasker JJ.

J Rheumatol. 2019 Aug 1. pii: jrheum.190149. doi: 10.3899/jrheum.190149. [Epub ahead of print]

PMID:
31371651
5.

Fibromyalgia 2019: Myths and Realities.

Ablin JN.

Isr Med Assoc J. 2019 Jun;21(6):426-428. Review. No abstract available.

6.

The role of patient organisation in fibromyalgia and related syndromes.

Gur S, Ablin JN.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):11-12. Epub 2019 Feb 6. No abstract available.

7.

Brain responses to other people's pain in fibromyalgia: a magnetoencephalography study.

Goldstein A, Zeev-Wolf M, Herz N, Ablin JN.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):70-74. Epub 2019 Jan 9.

PMID:
30652680
8.

High prevalence of fibromyalgia among Israeli school teachers.

Buskila Y, Buskila D, Jacob G, Ablin JN.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):21-26. Epub 2019 Jan 9.

PMID:
30652679
9.

Volitional limbic neuromodulation exerts a beneficial clinical effect on Fibromyalgia.

Goldway N, Ablin J, Lubin O, Zamir Y, Keynan JN, Or-Borichev A, Cavazza M, Charles F, Intrator N, Brill S, Ben-Simon E, Sharon H, Hendler T.

Neuroimage. 2019 Feb 1;186:758-770. doi: 10.1016/j.neuroimage.2018.11.001. Epub 2018 Nov 5.

PMID:
30408596
10.

Cardiovascular Autonomic Profile in Women With Premenstrual Syndrome.

Koifman R, Dayan L, Ablin JN, Jacob G.

Front Physiol. 2018 Oct 1;9:1384. doi: 10.3389/fphys.2018.01384. eCollection 2018.

11.

Does the cognitive index of the symptom severity scale evaluate cognition? Data from subjective and objective cognitive measures in fibromyalgia.

Elkana O, Falcofsky AK, Shorer R, Bar-On Kalfon T, Ablin JN.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):51-57. Epub 2018 Sep 20.

PMID:
30299249
12.

Treading on an Eggshell.

Gurevich-Shapiro A, Pasternak Y, Ablin JN.

Isr Med Assoc J. 2018 Sep;20(9):594. No abstract available.

13.

Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?

Aloush V, Dotan I, Ablin JN, Elkayam O.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):32-36. Epub 2018 Jun 25.

PMID:
29998822
14.

Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients.

Furer V, Hazan E, Mor A, Segal M, Katav A, Aloush V, Elkayam O, George J, Ablin JN.

Pain Res Manag. 2018 May 13;2018:7257681. doi: 10.1155/2018/7257681. eCollection 2018.

15.

Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in American and Israeli rheumatoid arthritis patients.

Merdler-Rabinowicz R, Hassidim A, Hellou R, Merdler I, Hauser W, Ablin JN.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):575-580. Epub 2018 Feb 15.

16.

[CENTRALIZED PAIN AND FIBROMYALGIA: WHAT DO WE MEAN WHEN WE SAY "IT'S ALL IN YOUR HEAD"?]

Ablin JN.

Harefuah. 2017 Dec;156(12):762-766. Review. Hebrew.

PMID:
29292613
17.

Increased Sympathetic Outflow Induces Adaptation to Acute Experimental Pain.

Dayan L, Hochberg U, Nahman-Averbuch H, Brill S, Ablin JN, Jacob G.

Pain Pract. 2018 Mar;18(3):322-330. doi: 10.1111/papr.12606. Epub 2017 Aug 9.

PMID:
28627793
18.

A Comparative Evaluation of the 2011 and 2016 Criteria for Fibromyalgia.

Ablin JN, Wolfe F.

J Rheumatol. 2017 Aug;44(8):1271-1276. doi: 10.3899/jrheum.170095. Epub 2017 Jun 1.

PMID:
28572464
19.

Self-Reported Childhood Maltreatment and Traumatic Events among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis.

Hellou R, Häuser W, Brenner I, Buskila D, Jacob G, Elkayam O, Aloush V, Ablin JN.

Pain Res Manag. 2017;2017:3865249. doi: 10.1155/2017/3865249. Epub 2017 Jan 11.

20.

Management of fibromyalgia: practical guides from recent evidence-based guidelines.

Häuser W, Ablin J, Perrot S, Fitzcharles MA.

Pol Arch Intern Med. 2017 Jan 4;127(1):47-56. doi: 10.20452/pamw.3877. Epub 2017 Jan 4. Review.

21.

A novel paradigm to evaluate conditioned pain modulation in fibromyalgia.

Schoen CJ, Ablin JN, Ichesco E, Bhavsar RJ, Kochlefl L, Harris RE, Clauw DJ, Gracely RH, Harte SE.

J Pain Res. 2016 Sep 26;9:711-719. eCollection 2016.

22.

Distinctive personality profiles of fibromyalgia and chronic fatigue syndrome patients.

Ablin JN, Zohar AH, Zaraya-Blum R, Buskila D.

PeerJ. 2016 Sep 13;4:e2421. doi: 10.7717/peerj.2421. eCollection 2016.

23.

Axonal Polyneuropathy as an Unusual Manifestation of Acute Epstein-Barr Virus Infection in an Adult.

Kremer K, Dekel M, Gadoth A, Jacob G, Ablin JN.

Isr Med Assoc J. 2016 May;18(5):299-300. No abstract available.

24.

Cognitive functioning in fibromyalgia: The central role of effort.

Bar-On Kalfon T, Gal G, Shorer R, Ablin JN.

J Psychosom Res. 2016 Aug;87:30-6. doi: 10.1016/j.jpsychores.2016.06.004. Epub 2016 Jun 7.

PMID:
27411749
25.

Prevalence of Axial Spondyloarthritis Among Patients With Fibromyalgia: A Magnetic Resonance Imaging Study With Application of the Assessment of SpondyloArthritis International Society Classification Criteria.

Ablin JN, Eshed I, Berman M, Aloush V, Wigler I, Caspi D, Likhter M, Wollman J, Paran D, Anouk M, Elkayam O.

Arthritis Care Res (Hoboken). 2017 May;69(5):724-729. doi: 10.1002/acr.22967.

26.

Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects.

Ali-Saleh M, Sarig G, Ablin JN, Brenner B, Jacob G.

PLoS One. 2016 Jul 5;11(7):e0158652. doi: 10.1371/journal.pone.0158652. eCollection 2016.

27.

Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.

Boltin D, Kamenetsky Z, Perets TT, Snir Y, Sapoznikov B, Schmilovitz-Weiss H, Ablin JN, Dickman R, Niv Y.

Dig Dis Sci. 2017 Mar;62(3):633-638. doi: 10.1007/s10620-016-4234-y. Epub 2016 Jun 23.

PMID:
27339637
28.

Fibromyalgia syndrome: novel therapeutic targets.

Ablin JN, Häuser W.

Pain Manag. 2016 May;6(4):371-81. doi: 10.2217/pmt-2016-0007. Epub 2016 Jun 14. Review.

PMID:
27296699
29.

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.

Ablin JN, Elkayam O, Fitzcharles MA.

Rambam Maimonides Med J. 2016 Apr 19;7(2). doi: 10.5041/RMMJ.10239.

30.

Building up the pressure on chronic pain.

Ablin JN, Efrati S, Buskila D.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S3-5. Epub 2016 Apr 1. No abstract available.

PMID:
27049512
31.

Prevalence and characteristics of fibromyalgia among HIV-positive patients in southern Israel.

Dotan I, Riesenberg K, Toledano R, Schlaeffer F, Smolyakov A, Saidel-Odes L, Wechsberg O, Ablin JN, Novack V, Buskila D.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S34-9. Epub 2016 Mar 3.

PMID:
26940885
33.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
34.

Effect of Fibromyalgia Symptoms on Outcome of Spinal Surgery.

Ablin JN, Berman M, Aloush V, Regev G, Salame K, Buskila D, Lidar Z.

Pain Med. 2017 Apr 1;18(4):773-780. doi: 10.1093/pm/pnw232.

PMID:
28339521
35.

Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome.

Ablin JN, Aloush V, Brill A, Berman M, Barzilai M, Caspi D, Mandelboim M, Levartovsky D, Polachek A, Wolman Y, Paran D, Barkagan M, Elkayam O.

Reumatismo. 2015 Sep 16;67(2):57-61. doi: 10.4081/reumatismo.2015.823.

36.

"Real-life" treatment of chronic pain: Targets and goals.

Ablin JN, Buskila D.

Best Pract Res Clin Rheumatol. 2015 Feb;29(1):111-9. doi: 10.1016/j.berh.2015.04.020. Epub 2015 May 20. Review.

PMID:
26267005
37.

Update on the genetics of the fibromyalgia syndrome.

Ablin JN, Buskila D.

Best Pract Res Clin Rheumatol. 2015 Feb;29(1):20-8. doi: 10.1016/j.berh.2015.04.018. Epub 2015 May 18. Review.

PMID:
26266996
38.

Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial.

Efrati S, Golan H, Bechor Y, Faran Y, Daphna-Tekoah S, Sekler G, Fishlev G, Ablin JN, Bergan J, Volkov O, Friedman M, Ben-Jacob E, Buskila D.

PLoS One. 2015 May 26;10(5):e0127012. doi: 10.1371/journal.pone.0127012. eCollection 2015.

39.

Fibromyalgia.

Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B.

Nat Rev Dis Primers. 2015 Aug 13;1:15022. doi: 10.1038/nrdp.2015.22. Review.

PMID:
27189527
40.

Syphilis: an unusual manifestation?

Bezalely S, Jacob G, Flusser G, Ablin J.

BMJ Case Rep. 2014 Sep 19;2014. pii: bcr2014204871. doi: 10.1136/bcr-2014-204871.

41.

Treating juvenile fibromyalgia: cognitive-behavioral therapy, exercise and pharmacotherapy.

Buskila D, Ablin JN.

Pain Manag. 2013 Sep;3(5):323-4. doi: 10.2217/pmt.13.37. No abstract available.

42.

Predicting fibromyalgia, a narrative review: are we better than fools and children?

Ablin JN, Buskila D.

Eur J Pain. 2014 Sep;18(8):1060-6. doi: 10.1002/j.1532-2149.2014.00481.x. Epub 2014 Mar 11. Review.

PMID:
24619570
43.

[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].

Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, Mevorach D, Mader R, Sachar T, Amital D, Buskila D; Israeli Rheumatology Association.

Harefuah. 2013 Dec;152(12):742-7, 751, 750. Hebrew.

PMID:
24483001
44.

The first Israeli fibromyalgia congress, February 2013.

Amital H, Ablin J, Aloush V, Häuser W, Buskila D.

Isr Med Assoc J. 2013 Dec;15(12):789-92. No abstract available.

45.

Tocilizumab in adult-onset Still's disease: the Israeli experience.

Elkayam O, Jiries N, Dranitzki Z, Kivity S, Lidar M, Levy O, Ablin J, Abu-Shakra M, Savargyl-Maman H, Padova H, Caspi D, Rosner I.

J Rheumatol. 2014 Feb;41(2):244-7. doi: 10.3899/jrheum.130881. Epub 2014 Jan 15.

PMID:
24429168
46.

Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines.

Fitzcharles MA, Shir Y, Ablin JN, Buskila D, Amital H, Henningsen P, Häuser W.

Evid Based Complement Alternat Med. 2013;2013:528952. doi: 10.1155/2013/528952. Epub 2013 Nov 26. Review.

47.

Effects of sleep restriction and exercise deprivation on somatic symptoms and mood in healthy adults.

Ablin JN, Clauw DJ, Lyden AK, Ambrose K, Williams DA, Gracely RH, Glass JM.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6 Suppl 79):S53-9. Epub 2013 Nov 15.

PMID:
24373363
48.

Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.

Ablin J, Fitzcharles MA, Buskila D, Shir Y, Sommer C, Häuser W.

Evid Based Complement Alternat Med. 2013;2013:485272. doi: 10.1155/2013/485272. Epub 2013 Nov 21. Review.

49.

Spa treatment (balneotherapy) for fibromyalgia-a qualitative-narrative review and a historical perspective.

Ablin JN, Häuser W, Buskila D.

Evid Based Complement Alternat Med. 2013;2013:638050. doi: 10.1155/2013/638050. Epub 2013 Jul 31.

50.

Fibromyalgia syndrome--novel therapeutic targets.

Ablin JN, Buskila D.

Maturitas. 2013 Aug;75(4):335-40. doi: 10.1016/j.maturitas.2013.05.004. Epub 2013 Jun 3. Review.

PMID:
23742873

Supplemental Content

Support Center